Germline AGO2 mutations impair RNA interference and human neurological development
暂无分享,去创建一个
R. Pfundt | M. Reijnders | G. Meister | H. Brunner | D. Mitter | Alexander Bartholomäus | Z. Ignatova | T. Kleefstra | T. Roscioli | K. Boycott | T. Hartley | E. Tan | A. Telegrafi | D. Lessel | J. Denecke | G. Mirzaa | P. Rump | M. McDonald | M. Osmond | C. Kubisch | Kerith-Rae Dias | E. Zonneveld-Huijssoon | M. Willemsen | D. Zeitler | D. Dyment | M. Sinnema | J. Lazier | S. Kindler | R. Jamra | Katharina Löhner | A. Stegmann | T. Kovacevic | Erica H. Gerkes | H. Lemmink | Carey-Anne Evans | A. Bruckmann | A. McConkie-Rosell | S. Syrbe | B. Lozić | E. Gerkes | J. Johannsen | A. Merkenschlager | J. Pappas | P. Prasun | D. Le Duc | E. Tan | B. Cham | H. Kreienkamp | K. McWalter | R. Rabin | Ivana Lessel | T. Gardeitchik | T. Busa | C. Missirian | K. Foss | M. Lewis | S. Lüttgen | Fatemeh Hassani Nia | B. Panis | Claudia Schob | Andriy Kazantsev | P. Andrews | V. Martens | Veronika Graus | L. Ramsdell | J. Mortreux | I. Mannucci | Chieko Chijiwa | Kimberly Foss | Linda A. Ramsdell | Margot R. F. Reijnders | T. Kovačević
[1] F. Kortüm,et al. Truncating mutations in SHANK3 associated with global developmental delay interfere with nuclear β‐catenin signaling , 2020, Journal of neurochemistry.
[2] T. Meitinger,et al. Exome Sequencing in Children. , 2019, Deutsches Arzteblatt international.
[3] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[4] K. M. McSweeney,et al. Analyses of LMNA-negative juvenile progeroid cases confirms biallelic POLR3A mutations in Wiedemann–Rautenstrauch-like syndrome and expands the phenotypic spectrum of PYCR1 mutations , 2018, Human Genetics.
[5] G. Meister,et al. Regulation of microRNA biogenesis and its crosstalk with other cellular pathways , 2018, Nature Reviews Molecular Cell Biology.
[6] H. Stefánsson,et al. MAP1B mutations cause intellectual disability and extensive white matter deficit , 2018, Nature Communications.
[7] Joseph P. McCleery,et al. Diagnosis and management of Cornelia de Lange syndrome: first international consensus statement , 2018, Nature Reviews Genetics.
[8] K. Boycott,et al. Diagnostic clarity of exome sequencing following negative comprehensive panel testing in the neonatal intensive care unit , 2018, American journal of medical genetics. Part A.
[9] L. A. Lowery,et al. The Role of the Microtubule Cytoskeleton in Neurodevelopmental Disorders , 2018, Front. Cell. Neurosci..
[10] Chirlmin Joo,et al. Helix‐7 in Argonaute2 shapes the microRNA seed region for rapid target recognition , 2018, The EMBO journal.
[11] Vinodh Narayanan,et al. De Novo Missense Mutations in DHX30 Impair Global Translation and Cause a Neurodevelopmental Disorder. , 2018, American journal of human genetics.
[12] J. Rosenfeld,et al. De Novo Missense Mutations in DHX30 Impair Global Translation and Cause a Neurodevelopmental Disorder. , 2017, American journal of human genetics.
[13] Shan Chang,et al. Exploring the RNA‐bound and RNA‐free human Argonaute‐2 by molecular dynamics simulation method , 2017, Chemical biology & drug design.
[14] G. Schratt,et al. MicroRNAs in neural development: from master regulators to fine-tuners , 2017, Development.
[15] Julia C. Engelmann,et al. Phosphorylation of Argonaute proteins affects mRNA binding and is essential for microRNA‐guided gene silencing in vivo , 2017, The EMBO journal.
[16] Tuo Li,et al. An Argonaute phosphorylation cycle promotes microRNA-mediated silencing , 2016, Nature.
[17] W. Chung,et al. Clinical application of whole-exome sequencing across clinical indications , 2015, Genetics in Medicine.
[18] Michele Parrinello,et al. Enhancing Important Fluctuations: Rare Events and Metadynamics from a Conceptual Viewpoint. , 2016, Annual review of physical chemistry.
[19] J. Whitelegge,et al. The X-Linked-Intellectual-Disability-Associated Ubiquitin Ligase Mid2 Interacts with Astrin and Regulates Astrin Levels to Promote Cell Division. , 2016, Cell reports.
[20] James Y. Zou. Analysis of protein-coding genetic variation in 60,706 humans , 2015, Nature.
[21] G. Shan,et al. RNAi pathway participates in chromosome segregation in mammalian cells , 2015, Cell Discovery.
[22] Hairui Xi,et al. Ribozyme-enhanced single-stranded Ago2-processed interfering RNA triggers efficient gene silencing with fewer off-target effects , 2015, Nature Communications.
[23] K. Gunsalus,et al. Assembly and analysis of eukaryotic Argonaute–RNA complexes in microRNA-target recognition , 2015, Nucleic acids research.
[24] R. Pfundt,et al. De Novo Mutations in CHAMP1 Cause Intellectual Disability with Severe Speech Impairment. , 2015, American journal of human genetics.
[25] G. Schratt,et al. A large‐scale functional screen identifies Nova1 and Ncoa3 as regulators of neuronal miRNA function , 2015, The EMBO journal.
[26] Michal Otyepka,et al. Insights into Stability and Folding of GNRA and UNCG Tetraloops Revealed by Microsecond Molecular Dynamics and Well-Tempered Metadynamics. , 2015, Journal of chemical theory and computation.
[27] D. Valle,et al. New Tools for Mendelian Disease Gene Identification: PhenoDB Variant Analysis Module; and GeneMatcher, a Web‐Based Tool for Linking Investigators with an Interest in the Same Gene , 2015, Human mutation.
[28] I. MacRae,et al. Gene regulation. Structural basis for microRNA targeting. , 2014 .
[29] I. MacRae,et al. Structural basis for microRNA targeting , 2014, Science.
[30] A. Battaglia,et al. Five children with deletions of 1p34.3 encompassing AGO1 and AGO3 , 2014, European Journal of Human Genetics.
[31] Ying Liu,et al. Evol and ProDy for bridging protein sequence evolution and structural dynamics , 2014, Bioinform..
[32] Stephan J Sanders,et al. A framework for the interpretation of de novo mutation in human disease , 2014, Nature Genetics.
[33] Christian Gilissen,et al. A Post‐Hoc Comparison of the Utility of Sanger Sequencing and Exome Sequencing for the Diagnosis of Heterogeneous Diseases , 2013, Human mutation.
[34] Ji-Joon Song,et al. Dynamic anchoring of the 3'-end of the guide strand controls the target dissociation of Argonaute-guide complex. , 2013, Journal of the American Chemical Society.
[35] Jing Huang,et al. CHARMM36 all‐atom additive protein force field: Validation based on comparison to NMR data , 2013, J. Comput. Chem..
[36] Giacomo Fiorin,et al. Using collective variables to drive molecular dynamics simulations , 2013 .
[37] G. Meister,et al. Turning catalytically inactive human Argonaute proteins into active slicer enzymes , 2013, Nature Structural &Molecular Biology.
[38] A. Orth,et al. Akt-mediated phosphorylation of argonaute 2 downregulates cleavage and upregulates translational repression of MicroRNA targets. , 2013, Molecules and Cells.
[39] Y. Goo,et al. Activity-dependent synaptic localization of processing bodies and their role in dendritic structural plasticity , 2013, Journal of Cell Science.
[40] D. Horn,et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study , 2012, The Lancet.
[41] Yong Huang,et al. Slicing-Independent RISC Activation Requires the Argonaute PAZ Domain , 2012, Current Biology.
[42] I. MacRae,et al. The Crystal Structure of Human Argonaute2 , 2012, Science.
[43] Y. Tomari,et al. The N domain of Argonaute drives duplex unwinding during RISC assembly , 2012, Nature Structural &Molecular Biology.
[44] Steffen Schmidt,et al. Crystal structure of the MID-PIWI lobe of a eukaryotic Argonaute protein , 2011, Proceedings of the National Academy of Sciences.
[45] G. Schratt. microRNAs at the synapse , 2009, Nature Reviews Neuroscience.
[46] D. Bartel. MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.
[47] W. Filipowicz,et al. Dendrites of Mammalian Neurons Contain Specialized P-Body-Like Structures That Respond to Neuronal Activation , 2008, The Journal of Neuroscience.
[48] M. Kiebler,et al. Dynamic Interaction between P-Bodies and Transport Ribonucleoprotein Particles in Dendrites of Mature Hippocampal Neurons , 2008, The Journal of Neuroscience.
[49] Ligang Wu,et al. Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. , 2008, Molecular cell.
[50] J. Steitz,et al. Switching from Repression to Activation: MicroRNAs Can Up-Regulate Translation , 2007, Science.
[51] Anthony K. L. Leung,et al. Quantitative analysis of Argonaute protein reveals microRNA-dependent localization to stress granules , 2006, Proceedings of the National Academy of Sciences.
[52] T. Tuschl,et al. Identification of Novel Argonaute-Associated Proteins , 2005, Current Biology.
[53] Laxmikant V. Kalé,et al. Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..
[54] R. Shiekhattar,et al. Human RISC Couples MicroRNA Biogenesis and Posttranscriptional Gene Silencing , 2005, Cell.
[55] H. Blau,et al. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies , 2005, Nature Cell Biology.
[56] D. Barford,et al. Structural insights into mRNA recognition from a PIWI domain–siRNA guide complex , 2005, Nature.
[57] G. Hannon,et al. Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity , 2004, Science.
[58] J. M. Thomson,et al. Argonaute2 Is the Catalytic Engine of Mammalian RNAi , 2004, Science.
[59] T. Tuschl,et al. Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. , 2004, Molecular cell.
[60] D. Patel,et al. Structural basis for overhang-specific small interfering RNA recognition by the PAZ domain , 2004, Nature.
[61] Henning Urlaub,et al. Single-Stranded Antisense siRNAs Guide Target RNA Cleavage in RNAi , 2002, Cell.
[62] W. L. Jorgensen,et al. Comparison of simple potential functions for simulating liquid water , 1983 .
[63] G. Kops,et al. Kinetochore Malfunction in Human Pathologies. , 2017, Advances in experimental medicine and biology.